Lichen planus pemphigoides with antibodies against the BP180 C-terminal domain induced by pembrolizumab in a melanoma patient
Satoshi Yoshida
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
Search for more papers by this authorCorresponding Author
Ken Shiraishi
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
Correspondence
Ken Shiraishi, Department of Dermatology, Ehime University Graduate School of Medicine, Shitsukawa, Toon city, Ehime, 791-0295, Japan.
Email: [email protected]
Search for more papers by this authorKazuki Yatsuzuka
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
Search for more papers by this authorHideki Mori
Department of Plastic and Reconstructive surgery, Ehime University Graduate School of Medicine, Ehime, Japan
Search for more papers by this authorHiroshi Koga
Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan
Search for more papers by this authorNorito Ishii
Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan
Search for more papers by this authorKoji Sayama
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
Search for more papers by this authorSatoshi Yoshida
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
Search for more papers by this authorCorresponding Author
Ken Shiraishi
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
Correspondence
Ken Shiraishi, Department of Dermatology, Ehime University Graduate School of Medicine, Shitsukawa, Toon city, Ehime, 791-0295, Japan.
Email: [email protected]
Search for more papers by this authorKazuki Yatsuzuka
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
Search for more papers by this authorHideki Mori
Department of Plastic and Reconstructive surgery, Ehime University Graduate School of Medicine, Ehime, Japan
Search for more papers by this authorHiroshi Koga
Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan
Search for more papers by this authorNorito Ishii
Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan
Search for more papers by this authorKoji Sayama
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan
Search for more papers by this authorCONFLICT OF INTEREST
None declared.
Supporting Information
| Filename | Description |
|---|---|
| jde16006-sup-0001-TableS1.jpgJPEG image, 744 KB | Table S1 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Sekiya A, Kodera M, Yamaoka T, Iwata Y, Usuda T. A case of lichen planus pemphigoides with autoantibodies to the NC16a and C-terminal domains of BP180 and to desmoglein-1. Br J Dermatol. 2014; 171: 1230–5.
- 2Schmidgen MI, Butsch F, Schadmand-Fischer S, Steinbrink K, Grabbe S, Weidenthaler-Barth B, et al. Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma. J Dtsch Dermatol Ges. 2017; 15: 742–5.
- 3Kwon CW, Murthy RK, Kudchadkar R, Stoff BK. Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma. JAAD Case Rep. 2020; 6: 1045–7.
- 4Okada H, Kamiya K, Murata S, Sugihara T, Sato A, Maekawa T, et al. Case of lichen planus pemphigoides after pembrolizumab therapy for advanced urothelial carcinoma. J Dermatol. 2020; 47: e321–e322.
- 5Sugawara A, Koga H, Abe T, Ishii N, Nakama T. Lichen planus-like lesion preceding bullous pemphigoid development after programmed cell death protein-1 inhibitor treatment. J Dermatol. 2021; 48: 401–4.
Citing Literature
